Back to results
US 2025/0152530 A1Published application
Sotalol hydrochloride dosing
AssigneeAltaThera Pharmaceuticals LLC
InventorsJohn Charin Somberg, Brandon Ira Kashfian, Janos Molnar
Life of this patent
Estimating the term…
Abstract
The present invention provides novel methods of administering sotalol hydrochloride to patients in need thereof.
Claims20
A method of administering sotalol hydrochloride, comprising:
- a. administering a single intravenous (IV) dose of 55-125 mg sotalol hydrochloride over a period of 1 hour to a subject having had symptomatic atrial fibrillation or atrial flutter, wherein the subject is currently in sinus rhythm;
- and
- b. after completion of the IV dose, administering oral dosing of one or more oral dose of sotalol hydrochloride to the subject in an amount of 80 mg or 120 mg.
Dependencies are inferred from the claim text.